Jannik Faliu is Co-Founder and Co-CEO of Immunordic, a Copenhagen-based biotech company pioneering fast and affordable nanobody discovery for research, diagnostics, and therapeutics.

Jannik holds a Master's degree in Neurobiology and Neurosciences from the University of Copenhagen and gained industry experience at DTU - Technical University of Denmark, REBBLS, and Blu A/S.

A 2nd-time founder with a background in Biotech and Neuroscience, Jannik co-led Immunordic's strategic pivot from traditional wet lab methods to an AI and machine learning-based approach for protein binder identification.

Jannik and co-founder Emil Arvedsen built Immunordic from the ground up at CPH-labs in Copenhagen, achieving proof of concept for identifying a tailored nanobody in under a month after eight iterations and two years of development.

Immunordic's platform, backed by InnoFounder, Beyond Beta, and public funding bodies, aims to democratize access to nanobodies by offering an automated library of 100 billion nanobodies for targeted therapeutics, diagnostics, and academic research.